CDMO News
KD Pharma Group Completes Acquisition of dsm-firmenich’s Marine Lipids Business
KD Pharma Group, a contract development and manufacturing organisation (CDMO) specialising in pharmaceutical and nutritional lipids, has successfully completed the acquisition of dsm-firmenich’s Marine Lipids business. The transaction, initially announced in July, has been finalised following the receipt of necessary
2 October 2024